A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1186 participants.

Also called NCT01809327

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,186 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01809327
  • EudraCT 2011-000400-17
Other papers using this trial's data
  • Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes Diabetes care, 2016-03 DOI, PubMed 26786577

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Brazil, Czechia, Hungary, Mexico, Puerto Rico, Romania, Russia, Slovakia, South Africa, South Korea, Ukraine (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01809327. Randomized; quadruple masking; primary purpose treatment. Start 2013-06-04 (actual); primary completion 2014-12-02 (actual). Results posted on 2016-01-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Canagliflozin 100 mg
Intervention (Drug)
Canagliflozin 300 mg
Intervention (Drug)
Metformin XR
Lead sponsor
Janssen Research & Development, LLC (class: industry)

Record details

Record id
cardio:ct-nct01809327
Content hash
f71efc37cd8cd57e12b4e2ef1cc7c02e6e32e5de0b95926741f7b05f2206a64b